Abstract. Temporomandibular disorder (TMD) is a complex and multifactorial disease, with inflammatory response and cartilage destruction usually associated with its etiology. Notch1 is a type I transmembrane receptor, which is critical in determining the growth, differentiation and survival of various cell types. However, its role and mechanism in interleukin (IL)-1β-stimulated temporomandibular chondrocytes remain to be elucidated. In the present study, chondrocytes were isolated from Sprague-Dawley rats and stimulated by IL-1β at a concentration of 10 ng/ml, and the expression of Notch1 was inhibited by small interfering RNA. The expression levels of Notch1 and Notch1 intracellular domain (NICD) were analyzed using reverse transcription-quantitative polymerase chain reaction and western blot analyses. Matrix metalloproteinases (MMPs) and the tissue inhibitor of metalloproteinases (TIMPs) were assessed using western blot analysis, and nuclear factor-κB (NF-κB) was also analyzed. Compared with the control, IL-1β stimulation increased the expression of Notch1 and NICD. In addition, IL-1β stimulation increased the secretion of tumor necrosis factor-α and IL-6, and the expression of intercellular adhesion molecule 1 and inducible nitric oxide synthase. By contrast, inhibition of Notch1 reduced these inflammatory responses by suppressing the nuclear translocation and phosphorylation of NF-κB p65. The inhibition of Notch1 also reduced the expression of MMPs and increased the expression of TIMP-1. These data suggested that the inhibition of Notch1 prevented the IL-1β-induced inflammatory response partly by inhibiting the NF-кB signaling pathway in temporomandibular chondrocytes. The inhibition of Notch1 suppressed cartilage destruction by modulating the balance between MMPs and TIMP-1, therefore, inhibition of Notch1 may be a mechanism for the treatment of TMD.
Introduction
Temporomandibular disorder (TMD) comprises a series of conditions, which cause pain and dysfunction in the muscles and joints between the lower jaw and the base of the skull. TMD is a complex and multifactorial disease, with physical, social and psychological factors usually associated with its etiology (1, 2) . Although progress has been made, the precise pathogenesis of TMD remains to be fully elucidated, which leads to difficulty in diagnosis and therapy. Usually, the temporomandibular cartilage withstands pressures of frequent jaw movement and biting hard food (3) . Abnormal elevated intra-articular pressure and local inflammatory response are important in TMD. The differential expression of inflammatory cytokines has been found in patients with TMD, including monocyte chemotactic protein 1, interleukin (IL)-1 and IL-8 (4) . Inflammation can also stimulate the production of matrix metalloproteinases (MMPs), downregulate the expression of tissue inhibitor of metalloproteinases (TIMPs) and accelerate the degradation of cartilage matrix (5) . An imbalance between MMPs and TIMPs has been reported to be important in the progression of TMD (6) .
IL-1 is a potent pro-inflammatory cytokine, which functions as the gatekeeper for inflammation (7) . It is produced by a variety of cells and acts on almost every organ system of the body. IL-1 consists of two distinct proteins (IL-1α and IL-1β), which bind to the type 1 IL-1 receptor to activate a downstream pro-inflammatory pathway (8) . IL-1β, a cytokine released by synovial cells and macrophages, causes inflammation of the articular cartilage (9) .
The Notch signaling pathway consists of a family of four type I transmembrane receptors (Notch1-4), which undergo proteolytic processing by a furin-like convertase during transit to the cell surface (10) . It is important in the growth, differentiation and survival of various cell types in diverse tissues (11 (14, 15) . Furthermore, inflammatory mediators can increase the expression of Notch (16) , and the upregulation of Notch signaling elevates responses to interferon-γ, leading to increased expression of inflammatory cytokines in macrophages (17, 18) . However, the role of Notch1 signaling in IL-1β-stimulated temporomandibular chondrocytes remains to be elucidated. The present study investigated whether the inhibition of Notch1 is able to inhibit inflammatory responses and cartilage destruction in TMD by establishing an in vitro model using temporomandibular chondrocytes.
Materials and methods
Isolation and culture of chondrocytes. The temporomandibular chondrocytes were isolated from the articular cartilage of 15 male Sprague-Dawley rats (6-week-old; 140-160 g). Animal care and all procedures were performed according to institutional guidelines and were approved by the Ethics Committee of Shandong University (Shangdong, China). All animals were housed in the same room on a 12 h light:dark cycle at 22˚C and had full access to standard chow and water. All surgical procedures were performed under sodium pentobarbital anesthesia and all efforts were made to minimize suffering. Briefly, the harvested cartilage was minced and incubated in a trypsin-containing solution for 2 h at 37˚C. The minced cartilage was then washed with phosphate-buffered saline (PBS; Sigma-Aldrich; KGaA Millipore, Darmstadt, Germany) and incubated with 0.2% collagenase (Sigma-Aldrich; KGaA Millipore) at 37˚C overnight. Following digestion, the chondrocytes were collected via centrifugation at 800 x g for 15 min at 37˚C and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal calf serum (Gibco; Thermo Fisher Scientific, Inc.), 100 IU/ml penicillin and 100 µg/ml streptomycin (Gibco; Thermo Fisher Scientific, Inc.). The cells were serum-starved overnight prior to treatment. Cells in passages 1-3 were used in all experiments.
Cell treatment and gene inhibition. The primary temporomandibular chondrocytes were cultured at a density of 5,000 cells/well in DMEM at 37˚C in an atmosphere of 5% CO 2 and treated with 10 ng/ml IL-1β (Sigma-Aldrich; KGaA Millipore). The cells were harvested following incubation for 24 h. To inhibit the expression of Notch1, the cells were transfected with Notch1 small interfering (s)iRNA (GenePharma, Shanghai, China) or negative control siRNA using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). Experiments were performed 24 h following transfection. The cells in the Notch1 group were stimulated with IL-1β following inhibition of Notch1 by siRNA.
Nuclear protein extraction. The nuclear proteins of the chondrocytes were extracted using an NE-PER Nuclear and Cytoplasmic Extraction Reagent kit (Pierce; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The protein was quantified using the bicinchoninic acid (BCA) method (Bio-Rad Laboratories, Inc., Hercules, CA, USA). All extracts were stored at -80˚C until use.
Enzyme-linked immunosorbent assay (ELISA).
The inflammatory cytokines in the cell culture supernatant were measured using ELISA kits for tumor necrosis factor (TNF)-α and IL-6 (R&D Systems, Inc., Minneapolis, MN, USA), as described previously (19) . All spectrophotometric readings were performed using an absorption spectrometer (Thermo Fisher Scientific, Inc.).
Measurement of mRNA expression using reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
analysis. Total RNA was extracted from the cultured cells using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) and reverse transcribed to cDNA using SYBR-Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA). The 1 µg mRNA levels were measured using qPCR analysis. The thermocycling conditions for PCR amplification were as follows: 95˚C for 5 min, 36 cycles at 95˚C for 10 sec, annealing at 56˚C for 30 sec and elongation at 72˚C for 30 sec. The primer sequences were as follows: Notch1, forward 5'-CGG GTC CAC CAG TTT GAA TG-3' and reverse 5'-GTT GTA TTG GTT CGG CAC CAT-3'; intercellular adhesion molecule 1 (ICAM-1), forward 5'-TTG GAA GCC -TCA TCC G-3' and reverse 5'-CAA TGT TG C GAG ACC C-3'; inducible nitric oxide synthase (iNOS), forward 5'-GTT CTC AGC CCA ACA ATA CAA GA-3' and reverse 5'-GTG GAC GGG TCG ATG TCA C-3'; GAP DH, forward 5'-GGA TGA CCT TGC CCA CAG CCT-3' and reverse 5'-ATC TCT GC-CCC CTC TGCT GA-3'. qPCR was performed on the iCycler real-time PCR system (Bio-Rad Laboratories, Inc.) and relative quantification was performed using the comparative quantification (Cq) method (20) .
Western blot analysis. The concentrations of protein extracted from chondrocytes were quantified using the BCA method with a protein assay kit (Beyotime Institute of Biotechnology, Nantong, China). The samples (50 µg) were separated on 10% SDS-PAGE and electrophoretically transferred onto a polyvinylidene difluoride membrane (GE Healthcare Life Sciences, Piscataway, NJ, USA). The blots were blocked for 2 h with 5% non-fat dry milk in Tris-buffered saline at room temperature and then incubated overnight with anti-Notch1 (catalog no. 36085; 1:1,000), anti-NICD (catalog no. 4147; 1:1,000), anti-ICAM (catalog no. 4915; 1:1,000), anti-iNOS (catalog no. 13120; 1:1,000) obtained from Cell Signaling Technology, Inc., Danvers, MA, USA. Additional antibodies used were anti-MMP-1 (catalog no. ab137332; 1:500, Abcam, Cambridge, MA, USA), anti-MMP-9 (catalog no. 2270; 1:2,000), anti-TIMP-1 (catalog no. 8946; 1:1,000), anti-nuclear factor (NF)-κB p65 (catalog no. 8242; 1:1,000), anti-phosphorylated (p)-NF-κB p65 (catalog no. 4806; 1:1,000), anti-histone (catalog no. 7631; 1:1,000) and anti-β-actin antibodies (catalog no. 3700; 1:1,000) all obtained from Cell Signaling Technology, Inc., at 4˚C. Following washing with 0.1% TBS-Tween 20, the membranes were incubated with secondary horseradish peroxidase-conjugated IgG (catalog nos. ZB-2301 and ZB-2305; 1:1,000; ZSGB-BIO, Beijing, China) at room temperature for 2 h. The blots were then visualized using enhanced chemiluminescence with ECL reagents (Pierce; Thermo Fisher Scientific, Inc.).
Statistical analysis. Data are presented as the mean ± standard deviation from three independent experiments. SPSS software, version 13.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Intergroup comparisons were performed using Student's t-test (two-tailed) or one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference.
Results

IL-1β increases the expression of Notch1 and NICD.
Following stimulation of the temporomandibular chondrocytes with IL-1β, the expression levels of Notch1 and NICD were measured using RT-qPCR and western blot analyses. As shown in Fig. 1A -D, no differences were found between the control group and the PBS group. However, compared with the control group, IL-1β significantly increased the mRNA and protein expression levels of Notch1, and the protein expression of NICD. Notch1 siRNA significantly reduced the mRNA ( Fig. 2A) and protein ( Fig. 2B and C) expression levels of Notch1, whereas the negative control siRNA had no effect.
Notch1 inhibition reduces the IL-1β-induced inflammatory response.
Inflammation is important in the pathogenesis of TMD. In the present study, following stimulation of the chondrocytes with IL-1β, the secretion of TNF-α and IL-6 were examined, as was the mRNA and protein expression levels of ICAM-1 and iNOS. Stimulation with IL-1β increased the levels of TNF-α and IL-6 in the supernatants, whereas the inhibition of Notch1 by siRNA reduced these levels and control siRNA had no effect ( Fig. 3A and B) . In addition, the inhibition of Notch1 significantly reduced the IL-1β-induced mRNA ( Fig. 4A and B) and protein ( Fig. 4C-E) expression levels of ICAM-1 and iNOS (Fig. 4) . These results suggested that the inhibition of Notch1 suppressed the IL-1β-induced inflammatory response in chondrocytes.
Notch1 inhibition reduces the expression of MMPs and increases the expression of TIMP-1. An imbalance between
MMPs and TIMPs has been confirmed to be important in the progression of TMD. The present study investigated the effect of inhibiting Notch1 on the expression levels of MMPs and TIMP-1. Compared with the control, IL-1β stimulation increased the expression levels of MMP-1 and MMP-9 ( Fig. 5A-C) , and reduced the expression of TIMP-1 (Fig. 5D) . However, the inhibition of Notch1 had the opposite effect, reducing the expression levels of MMPs and increasing the expression of TIMP-1.
Notch1 inhibition suppresses IL-1β induced activation of NF-кB in chondrocytes.
The present study also investigated whether the protective effects of inhibiting Notch1 involved the NF-кB signaling pathway. The nuclear translocation of NF-κB p65 was analyzed using western blot analysis. As shown in Fig. 6A -D, the localization of NF-κB p65 was predominantly cytoplasmic prior to IL-1β stimulation, however, it was translocated to the nucleus when cells were stimulated with IL-1β. The inhibition of Notch1 suppressed this IL-1β-induced p65 nuclear translocation. The expression of p-p65 was also measured. Compared with the control, IL-1β increased the expression of p-p65 3-fold, whereas inhibition of Notch1 reduced the IL-1β-induced expression of p-p65 ( Fig. 6E and F) . These results suggested that the protective effect of Notch1 inhibition occurred, at least in part, through the NF-кB signaling pathway.
Discussion
TMD is an assorted set of clinical conditions characterized by pain and dysfunction of the masticatory muscles in the temporomandibular joint (TMJ) (21) . The prevalence of TMD varies between 5 and 86% depending on different epidemiological studies, diagnostic criteria and methods of assessment (22) . According to the latest understanding, inflammatory cytokines are the most important pathogenic factors involved in the pathogenesis of TMD (23), responsible for the loss of metabolic homeostasis by promoting catabolic and destructive processes. Among the numerous representatives of these inflammatory cytokines, the highest importance is attributed to IL-1β, TNF-α and IL-6. In the present study, temporomandibular chondrocytes were stimulated with IL-1β. Compared with the control group, IL-1β significantly induced the inflammatory response in vitro, including the secretion of TNF-α and IL-6, and mRNA and protein expression of ICAM-1 and iNOS. These results were accordance with previous findings in vivo (24) .
MMPs are a family of >20 metalloenzymes, which are crucial in tissue remodeling and cartilage degradation due to their ability to degrade extracellular matrix (25) . TIMPs are considered to be specific inhibitors of MMPs. An imbalance between the activity of MMPs and their inhibitors is considered to underlie cartilage destruction. The expression of MMP-2 and MMP-9 has been reported to increase in the rat trigeminal ganglion during the development of TMJ inflammation (26) . In the present study, it was found that IL-1β stimulation increased the expression of MMP-1 and MMP-9, and reduced the expression of TIMP-1, whereas the inhibition of Notch1 by siRNA reduced the expression of MMPs and increased the expression of TIMP-1. Therefore, maintaining the balance of MMPs/TIMP-1 is the precise mechanism by which the inhibition of Notch1 prevents cartilage matrix degradation. This prompted investigation of the probable cell signaling transduction. NF-κB is pivotal in regulating inflammation-associated genes (27) . Various stimuli, including pro-inflammatory cytokines, lead to the nuclear translocation of NF-κB p65 and subsequently to the upregulated transcription of various proinflammatory cytokines, including IL-1, TNFα, IL-6 and IL-8 (28) . NF-κB remains inactive in the cytoplasm through interaction with the inhibitory protein, inhibitor κB (IκB). The activation of NF-κB requires the phosphorylation and subsequent degradation of IκBα (29) . It has been demonstrated that the phosphorylation of p65 is critical for binding to its target sites on DNA (30) . Considering NF-κB is a pivotal regulator of the inflammatory response, the cross-talk between IL-1β and NF-κB in chondrocytes may be one of the major causes of TMJ inflammation. As expected, stimulation with IL-1β in the present study induced the nuclear translocation and phosphorylation of NF-κB p65, with an increased expression of inflammatory cytokines, including TNFα, IL-6, ICMA-1 and iNOS.
In conclusion, the results of the present study provide novel insights into the regulatory mechanisms of Notch1 in temporomandibular chondrocytes during TMD. IL-1β stimulation induced Notch1, and subsequent variation was associated with NF-κB pathway, which may be an important pathogenetic factor in the development of TMD. The present study, to the best of our knowledge, is the first to provide evidence that the inhibition of Notch1 effective treated TMD. However, further in vivo experiments are required to identify novel and potent agents for the prevention and treatment of TMD through the inhibition of Notch1.
